FMS - Company ID 0001333141
The table below shows Fresenius Medical Care AG's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|
| Operating cash flow | $179.80M | $832.45M | $112.29M | $315.42M | $481.18M | $175.32M |
| Capital expenditure | -$250.18M | -$417.75M | $199.63M | $147.36M | $124.42M | $117.17M |
| Investing cash flow | -$337.10M | -$477.60M | -$331.93M | -$217.21M | -$1.65B | -$451.95M |
| Dividends paid | $0.00 | -$263.24M | - |
Fresenius Medical Care AG reported operating cash flow of $2.14B for fiscal year 2016. That is up 9.2% from $1.96B in fiscal 2015. Over the 10 fiscal years shown, operating cash flow grew from $1.20B (FY 2007) to $2.14B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| $0.00 |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $114.95M | -$393.78M | $116.21M | -$246.47M | $1.28B | $356.51M |